Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csermely

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Seminars in Cancer Biology|January 14, 2014
Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescencePeter Csermely, János Hódsági, Tamás Korcsmáros, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2003
Heat shock protein coinducers with no effect on protein denaturation specifically modulate the membrane lipid phaseZsolt Török, Nelly M Tsvetkova, Gábor Balogh, et al.
NPJ Systems Biology and Applications|June 13, 2017
Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapiesDezső Módos, Krishna C Bulusu, Dávid Fazekas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2023
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory studyAlessandro Mantovani, Alessandro Csermely, Annalisa Castagna, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional studyMichela Vergani, Nicolò Diego Borella, Mariangela Rizzo, et al.
Science Signaling|May 19, 2011
Network-based tools for the identification of novel drug targetsIllés J Farkas, Tamás Korcsmáros, István A Kovács, et al.
BMC Systems Biology|January 22, 2013
SignaLink 2 - a signaling pathway resource with multi-layered regulatory networksDávid Fazekas, Mihály Koltai, Dénes Türei, et al.
Cellular Signalling|October 17, 2001
The somatostatin analogue TT-232 induces apoptosis in A431 cells: sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinasesT Vántus, G Kéri, Z Krivickiene, et al.
Gut|May 23, 2024
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysisAlessandro Mantovani, Alessandro Csermely, Josh Bilson, et al.
Zebrafish|April 21, 2016
SignaFish: A Zebrafish-Specific Signaling Pathway ResourceKitti Csályi, Dávid Fazekas, Tamás Kadlecsik, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Seminars in Cancer Biology|January 14, 2014
Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescencePeter Csermely, János Hódsági, Tamás Korcsmáros, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2003
Heat shock protein coinducers with no effect on protein denaturation specifically modulate the membrane lipid phaseZsolt Török, Nelly M Tsvetkova, Gábor Balogh, et al.
NPJ Systems Biology and Applications|June 13, 2017
Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapiesDezső Módos, Krishna C Bulusu, Dávid Fazekas, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2023
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory studyAlessandro Mantovani, Alessandro Csermely, Annalisa Castagna, et al.
Diabetes, Obesity & Metabolism|March 14, 2025
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional studyMichela Vergani, Nicolò Diego Borella, Mariangela Rizzo, et al.
Science Signaling|May 19, 2011
Network-based tools for the identification of novel drug targetsIllés J Farkas, Tamás Korcsmáros, István A Kovács, et al.
BMC Systems Biology|January 22, 2013
SignaLink 2 - a signaling pathway resource with multi-layered regulatory networksDávid Fazekas, Mihály Koltai, Dénes Türei, et al.
Cellular Signalling|October 17, 2001
The somatostatin analogue TT-232 induces apoptosis in A431 cells: sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal-regulated kinasesT Vántus, G Kéri, Z Krivickiene, et al.
Gut|May 23, 2024
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysisAlessandro Mantovani, Alessandro Csermely, Josh Bilson, et al.
Zebrafish|April 21, 2016
SignaFish: A Zebrafish-Specific Signaling Pathway ResourceKitti Csályi, Dávid Fazekas, Tamás Kadlecsik, et al.
Pageof 28